Latest Breaking News On - Geoff nash george dollemore - Page 1 : comparemela.com

Destiny Pharma : Interim results for the six months ended 30 June 2023 -September 20, 2023 at 02:29 am EDT

Destiny Pharma plc Interim results for the six months ended 30 June 2023 Active discussions with potential partners for XF-73 nasal supported by new.

United statesBrighton and hoveUnited kingdomDebra barkerNigel birks harrietGeoff nash george dollemoreChris toveyNigel ruddShaun claydonInvestor meet companyCavendish capital markets limited nominated adviserSebela pharmaceuticalsNational institutePowerscourt groupDestiny pharmaNorth america

Destiny Pharma : Business Update

Business Update Continued progress on XF-73 partnering discussions Susan Koppy appointed to drive business development activities $2bn XF-73 Nasal market opportunity Brighton, United Kingdom - 29th June 2.

United kingdomBrighton and hoveUnited statesGeoff nash george dollemoreSusan koppyDebra barkerShaun claydonNigel birks harrietStrategic communicationsConsultant head of business developmentEuropean medicines agencyCap ltd nominated advisorDrug administrationDestiny pharmaConsultant headStaph aureus

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Posting of Annual Report and Notice of AGM

Investegate announcements from Destiny Pharma PLC, Posting of Annual Report and Notice of AGM

City ofUnited kingdomBrighton and hoveGeoff nash george dollemoreNeil clarkShaun claydonAnne hennecke andreas burckhardtJanhavi mohiteNigel birks harrietInvestor meet company platformCap ltd nominated advisorCap ltdStrategic communicationsMc servicesInvestor meet companyDestiny pharma

Investegate |Genedrive PLC Announcements | Genedrive PLC: £5 million Equity Prepayment Facility

Investegate |Genedrive PLC Announcements | Genedrive PLC: £5 million Equity Prepayment Facility
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomSaudi arabiaCity ofGeoff nash george dollemoreRuss shawOliver duckworthDavid buddPaul mcmanus anna dunphyIt forms part of united kingdomDiagnostics assessment programmeCap ltdLondon stock exchangeCompany assaysCompany antibiotic induced hearing lossEquity prepayment facilityRiverfort global opportunities

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Agreement with Sebela Pharmaceutical for NTCD-M3

Investegate announcements from Destiny Pharma PLC, Agreement with Sebela Pharmaceutical for NTCD-M3

United statesUnited kingdomBrighton and hoveAlan cookeJanhavi mohiteNigel birks harrietAnne hennecke andreas burckhardtShaun claydonNeil clarkand shaun claydonwillNeil clarkGeoff nash george dollemoreMc servicesBraintree laboratories incCap ltd nominated advisorDestiny pharmaInvestor meet company